No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single‐center experience

Summary Immunosuppressive drug tapering is currently the recommended treatment of BK virus (BKV) viremia after kidney transplantation; however, its exact modalities remain unclear. We retrospectively compared two consecutive strategies in 111 patients with sustained viremia: a gradual monitoring/tap...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplant international 2019-05, Vol.32 (5), p.481-492
Hauptverfasser:	Devresse, Arnaud, Tinel, Claire, Vermorel, Agathe, Snanoudj, Renaud, Morin, Lise, Avettand‐Fenoel, Véronique, Amrouche, Lucile, Scemla, Anne, Zuber, Julien, Legendre, Christophe, Rabant, Marion, Anglicheau, Dany
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibodies BK Virus Drug Administration Schedule Female Graft rejection Graft Survival Humans Immunosuppression Immunosuppression - methods Immunosuppressive agents Immunosuppressive Agents - therapeutic use Kidney transplantation Kidney Transplantation - adverse effects Kidney transplants Kidneys Male Middle Aged Monitoring Monoclonal antibodies Multivariate Analysis Mycophenolic acid Mycophenolic Acid - administration & dosage Nephropathy Patients Polyomavirus Infections - diagnosis Polyomavirus Infections - drug therapy Retrospective Studies Survival Tacrolimus Tacrolimus - administration & dosage Tapering Thymoglobulin Transplantation Viremia Viremia - virology Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!